These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6211136)

  • 1. Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.
    Modai J; Wolff M; Lebas J; Meulemans A; Manuel C
    Antimicrob Agents Chemother; 1982 Apr; 21(4):551-3. PubMed ID: 6211136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.
    Thirumoorthi MC; Buckley JA; Aravind MK; Kauffman RE; Dajani AS
    J Pediatr; 1981 Dec; 99(6):975-9. PubMed ID: 6458673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Presse Med; 1983 Jan; 12(3):139-42. PubMed ID: 6220351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxalactam therapy of bacterial meningitis in adults.
    Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The cerebrospinal fluid concentration of lamoxactam with reference to the therapy of gram-negative CNS infections].
    Nix WA; Hey O; Fabricius K
    Nervenarzt; 1982 Dec; 53(12):693-700. PubMed ID: 6218415
    [No Abstract]   [Full Text] [Related]  

  • 7. Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli.
    Fisher JF; Carter MJ; Parsons J; Rissing JP
    Antimicrob Agents Chemother; 1981 Feb; 19(2):218-21. PubMed ID: 6214985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of moxalactam into CSF.
    Landesman SH
    J Pediatr; 1982 Jul; 101(1):160-1. PubMed ID: 6211532
    [No Abstract]   [Full Text] [Related]  

  • 10. Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis.
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Antimicrob Agents Chemother; 1983 Jul; 24(1):126-8. PubMed ID: 6354077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
    Landesman SH; Corrado ML; Cherubin CC; Gombert M; Cleri D
    Am J Med; 1980 Jul; 69(1):92-8. PubMed ID: 6446240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of aztreonam into cerebrospinal fluid of patients with bacterial meningitis.
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Antimicrob Agents Chemother; 1986 Feb; 29(2):281-3. PubMed ID: 3717933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of moxalactam in the treatment of meningitis: efficacy and meningeal diffusion].
    Fosse T; Raoult D; David MF; Garnier JM; Arnolds M; Gallais H; Giraud F
    Pathol Biol (Paris); 1983 Jun; 31(6):477-9. PubMed ID: 6224124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of newer cephalosporins into cerebrospinal fluid.
    Cherubin CE; Eng RH; Norrby R; Modai J; Humbert G; Overturf G
    Rev Infect Dis; 1989; 11(4):526-48. PubMed ID: 2672238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM; Kaplan SL; Mason EO; Denson S; Pickering LK
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Olson DA; Hoeprich PD; Nolan SM; Goldstein E
    Ann Intern Med; 1981 Sep; 95(3):302-5. PubMed ID: 6455950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    Antimicrob Agents Chemother; 1980 Mar; 17(3):406-11. PubMed ID: 6448576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential value of cefoperazone in bacterial meningitis: experimental studies.
    Durack DT; Perfect JR
    Drugs; 1981; 22 Suppl 1():60-4. PubMed ID: 6269824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gram-negative bacillary meningitis. New therapy and changing concepts.
    Landesman SH; Cherubin CE; Corrado ML
    Arch Intern Med; 1982 May; 142(5):939-40. PubMed ID: 6211153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.